Sanofi Said To Be Leading Candidate For Elder Pharma Acquisition
This article was originally published in PharmAsia News
Sanofi appears to be muscling out GlaxoSmithKline and Pfizer as the likely highest bidder for Elder Pharmaceuticals by offering to buy all of its brands, according to sources.
You may also be interested in...
Third quarter earnings show Gilead’s Immunomedics buy paid off, but filgotinib’s path may narrow. The HIV and HCV franchises picked up from their COVID-19 lull.
US pharmacy group says that 10 to 12 states have indicated through an informal survey that they do not have the manpower or funding to implement the US FDA’s final MOU on inordinate compounding. They say what is at stake in these states is patient access to compounded medicines.
Mayo Clinic announces AI-based partnerships with Google and voice-analysis company Vocalis Health this week.